Investing

Top Analyst Upgrades and Downgrades: Activision, BioMarin, Ciena, Delta Air, GlaxoSmithKline, Procter & Gamble, Regeneron, Tesla and More

Tesla Inc. (NYSE: TSLA) was started with an Outperform rating at Wedbush with a $440 price target. That compares to the consensus price target of $331.60. The stock closed Thursday at $376.79.

Universal Health Services Inc. (NYSE: UHS) was downgraded to Sell from Neutral at Goldman Sachs. The stock has traded between $108.62 and $139.63 over the past year. The posted consensus price objective is $138.24. The stock ended trading on Thursday at $131.97.

Other key analysts upgrades and downgrades were seen in the following:

AMAG Pharmaceuticals Inc. (NASDAQ: AMAG) saw its price target lowered to $20.50 from $28 at B. Riley FBR. The analysts see the firm’s drug ciraparantag as an attractive pipeline addition although the firm does not expect FDA approval until the last half of 2021 and launch in 2022. The consensus price target is posted at $20.38. The stock closed Thursday at $16.99.

CECO Environmental Corp. (NASDAQ: CECE) was started with a Buy rating at Maxim Group with a $10 price target. That compares to the consensus target of $9. The shares closed Thursday at $7.53.

EMCOR Group Inc. (NYSE: EME) was started with a Hold rating at Maxim Group with a $68 price target. The consensus target is much higher at $85. The stock closed Thursday at $64.81.

Ford Motor Co. (NYSE: F) was started with a Buy rating at Deutsche Bank The 52-week trading range for the venerable automaker is $8.17 to $13.48, and the consensus price target is $9.89. The shares closed Thursday at $8.50.

New York Times Inc. (NYSE: NYT) was started with an Outperform rating at Evercore ISI. The 52-week trading range for the iconic newspaper is $18.08 to $28.72. The consensus price target is $28.25.

Trade Desk Inc. (NYSE TTD) saw its price target raised to $160 from $130 at Oppenheimer. That compares with the consensus price target of $129.71. The shares closed Thursday at $139.

WellCare Inc. (NYSE: WCG) was added to the Conviction Buy List at Goldman Sachs. The 52-week trading range is $187.06 to $324.99, and the consensus price objective is $334.60. The shares ended trading on Thursday at $244.35.

Thursday’s top analyst upgrades and downgrades¬†included Arena Pharmaceuticals, Autodesk, Coca-Cola, General Electric, Marvell, Monster Beverages, Nabors, Procter & Gamble, and more.